Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Nov 1;147(9):1333–1338.

Sulfite-containing Canadian pharmaceutical products available in 1991.

M Miyata 1, B Schuster 1, R Schellenberg 1
PMCID: PMC1336441  PMID: 1483237

Abstract

OBJECTIVE: To compile an inclusive list of Canadian pharmaceutical products available in 1991 that contained sulfites. DATA SOURCES: Written and oral responses from 94 pharmaceutical companies selected from the 1989 Compendium of Pharmaceuticals and Specialties. RESULTS: A list of sulfite-containing pharmaceutical products was compiled from data supplied by the 90 responding companies. Companies whose products contained no sulfites were separately identified. CONCLUSIONS: Sulfites are present in many pharmaceutical products and are one of many excipients and additives that have been reported to cause severe adverse reactions. The provided list should be a useful aid for health care practitioners when prescribing pharmaceutical products for sulfite-sensitive patients.

Full text

PDF
1333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acosta R., Granados J., Mourelle M., Perez-Alvarez V., Quezada E. Sulfite sensitivity: relationship between sulfite plasma levels and bronchospasm: case report. Ann Allergy. 1989 May;62(5):402–405. [PubMed] [Google Scholar]
  2. Bush R. K., Taylor S. L., Busse W. A critical evaluation of clinical trials in reactions to sulfites. J Allergy Clin Immunol. 1986 Jul;78(1 Pt 2):191–202. doi: 10.1016/0091-6749(86)90012-6. [DOI] [PubMed] [Google Scholar]
  3. Dalton-Bunnow M. F. Review of sulfite sensitivity. Am J Hosp Pharm. 1985 Oct;42(10):2220–2226. [PubMed] [Google Scholar]
  4. Dalton-Bunnow M. F. Sulfite content of drug products. Am J Hosp Pharm. 1985 Oct;42(10):2196–2201. [PubMed] [Google Scholar]
  5. Jamieson D. M., Guill M. F., Wray B. B., May J. R. Metabisulfite sensitivity: case report and literature review. Ann Allergy. 1985 Feb;54(2):115–121. [PubMed] [Google Scholar]
  6. Napke E., Stevens D. G. Excipients and additives: hidden hazards in drug products and in product substitution. Can Med Assoc J. 1984 Dec 15;131(12):1449–1452. [PMC free article] [PubMed] [Google Scholar]
  7. Schwartz H. J., Chester E. H. Bronchospastic responses to aerosolized metabisulfite in asthmatic subjects: potential mechanisms and clinical implications. J Allergy Clin Immunol. 1984 Oct;74(4 Pt 1):511–513. doi: 10.1016/0091-6749(84)90387-7. [DOI] [PubMed] [Google Scholar]
  8. Schwartz H. J. Sensitivity to ingested metabisulfite: variations in clinical presentation. J Allergy Clin Immunol. 1983 May;71(5):487–489. doi: 10.1016/0091-6749(83)90466-9. [DOI] [PubMed] [Google Scholar]
  9. Sher T. H., Schwartz H. J. Bisulfite sensitivity manifesting as an allergic reaction to aerosol therapy. Ann Allergy. 1985 Mar;54(3):224–226. [PubMed] [Google Scholar]
  10. Simon R. A. Adverse reactions to drug additives. J Allergy Clin Immunol. 1984 Oct;74(4 Pt 2):623–630. doi: 10.1016/0091-6749(84)90116-7. [DOI] [PubMed] [Google Scholar]
  11. Tichenor W. S. Sulfite sensitivity. 'Minor problem' proves major hazard for some. Postgrad Med. 1985 Oct;78(5):320, 322-5. [PubMed] [Google Scholar]
  12. Yang W. H., Purchase E. C. Adverse reactions to sulfites. CMAJ. 1985 Nov 1;133(9):865-7, 880. [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES